Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFIRFI Meaning: What Is an RFI?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Cancer and Other Health Effects Following the Chernobyl…

U.S. Department Of Health And Human Services·Maryland

Cancer and Other Health Effects Following the Chernobyl Accident in Ukraine

Closes 7/10/2026$5M – $20MRequest for Information
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is seeking information from qualified small businesses to conduct health effects studies in radiation-exposed populations in Ukraine. The studies will focus on cancer and other health effects in individuals exposed to radiation from the Chernobyl accident. The contractor will be responsible for managing concurrent studies, collecting biological specimens, developing and maintaining databases, and providing support to the NIH with data preparation and analysis. The anticipated period of performance is July 1, 2027, to June 30, 2032. • The contractor will update and verify the vital status and last known address of study participants. • The contractor will collect demographic, medical history, risk factor information, and data needed to reconstruct radiation doses to the thyroid gland and female breast. • The contractor will manage and support the dosimetry data previously collected by the contractor. • The contractor will calculate radiation doses to the thyroid gland and female breast from different exposure pathways. • The contractor will provide a brief description of collected data and samples. • The contractor will provide local office staff, who are fluent in English, Ukrainian, and Russian, for on-site administrative and financial management.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Eve Van Buren(Contracting Officer)

[email protected]

Key dates

Opened
6/22/2026
Closes
7/10/2026
Duration
60 months

Last updated

Details

Type
Request for Information
Industry
Healthcare and Medical Services
NAICS
541715
Solicitation №
NIH-OD-OALM-SBSS-DivB-06222026-2

Budget estimate

$5,000,000 – $20,000,000

The budget for this opportunity is difficult to estimate, as the document does not provide a specific dollar amount. However, based on the scope of work and the anticipated period of performance, it is likely that the contract value will be in the millions of dollars. The contractor will be responsible for managing concurrent studies, collecting biological specimens, and providing support to the NIH with data preparation and analysis, which will require significant resources and personnel. Additionally, the contractor will need to establish a local office in Ukraine, which will also incur significant costs. The estimated budget range is between $5 million and $20 million, depending on the number of studies, the complexity of the work, and the resources required. Factors that may influence the likely payment range include the number of study participants, the complexity of the dosimetry data, and the requirements for on-site administrative and financial management.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 65%

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 9/5/2024

U.S. National Institutes of Health·United States of America

64% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

63% match

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Closes 2/9/2027Opened 11/21/2025

U.S. Centers for Disease Control and Prevention - ERA·United States of America

63% match

Assessment and Evaluation of Emerging Health Conditions Relevant to the World Trade Center Health Program (U01)

Closes 11/30/2029Opened 8/22/2024

U.S. National Institutes of Health·United States of America

63% match

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 9/5/2024

U.S. Centers for Disease Control and Prevention - ERA·United States of America

62% match

Cooperative Research Agreements Related to the World Trade Center Health Program (U01)

Closes 12/8/2026Opened 8/22/2024

U.S. National Institutes of Health·United States of America

62% match

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/23/2023

U.S. National Institutes of Health·United States of America

62% match

Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 3/1/2028Opened 5/14/2025

U.S. National Institutes of Health·United States of America

62% match

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024

U.S. National Institutes of Health·United States of America

61% match

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Closes 10/11/2029Opened 3/10/2026

Mississippi Department of Health·Mississippi

61% match

Cancer Survivorship Evaluation

Closes 11/2/2026Opened 10/13/2026

U.S. National Institutes of Health·United States of America

61% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Closes 11/6/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

61% match

Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

Closes 1/24/2027Opened 6/2/2026

U.S. National Institutes of Health·United States of America

61% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

61% match

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 8/24/2023

U.S. National Institutes of Health·United States of America

61% match

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

U.S. Health Resources and Services Administration·United States of America

61% match

Radiation Exposure Screening and Education Program

Closes 8/31/2028Opened 8/13/2026

U.S. National Institutes of Health·United States of America

60% match

Limited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)

Closes 9/25/2028Opened 6/9/2025

U.S. National Institutes of Health·United States of America

60% match

Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/29/2023

U.S. National Institutes of Health·United States of America

60% match

Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)

Closes 1/7/2027Opened 9/21/2023

U.S. Centers for Disease Control - NCCDPHP·United States of America

60% match

Promoting Cancer Surveillance Workforce, Education, and Data Use

Closes 4/6/2027Opened 9/28/2026

U.S. National Institutes of Health·United States of America

60% match

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Closes 9/25/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

60% match

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Closes 1/7/2027Opened 8/15/2023

U.S. Centers for Disease Control - NCCDPHP·United States of America

60% match

Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations

Closes 2/5/2027Opened 9/3/2026

U.S. National Institutes of Health·United States of America

60% match

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Closes 9/7/2028Opened 11/12/2024